Literature DB >> 25123563

Characteristics of patients with yellow nail syndrome and pleural effusion.

Luis Valdés1, John T Huggins, Francisco Gude, Lucía Ferreiro, José M Alvarez-Dobaño, Antonio Golpe, María E Toubes, Francisco J González-Barcala, Esther San José, Steven A Sahn.   

Abstract

Yellow nail syndrome (YNS) can be associated with a pleural effusion (PE) but the characteristics of these patients are not well defined. We performed a systematic review across four electronic databases for studies reporting clinical findings, PE characteristics, and most effective treatment of YNS. Case descriptions and retrospective studies were included, unrestricted by year of publication. We reviewed 112 studies (150 patients), spanning a period of nearly 50 years. The male/female ratio was 1.2/1. The median age was 60 years (range: 0-88). Seventy-eight percent were between 41-80 years old. All cases had lymphoedema and 85.6% had yellow nails. PEs were bilateral in 68.3%. The appearance of the fluid was serous in 75.3%, milky in 22.3% and purulent in 3.5%. The PE was an exudate in 94.7% with lymphocytic predominance in 96% with a low count of nucleated cells. In 61 of 66 (92.4%) of patients, pleural fluid protein values were >3 g/dL, and typically higher than pleural fluid LDH. Pleurodesis and decortication/pleurectomy were effective in 81.8% and 88.9% of cases, respectively, in the treatment of symptomatic PEs. The development of YNS and PE occurs between the fifth to eighth decade of life and is associated with lymphoedema. The PE is usually bilateral and behaves as a lymphocyte-predominant exudate. The most effective treatments appear to be pleurodesis and decortication/pleurectomy.
© 2014 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chylothorax; decortication/pleurectomy; empyema; pleural effusion; pleurodesis; yellow nail syndrome

Mesh:

Year:  2014        PMID: 25123563     DOI: 10.1111/resp.12357

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Role of Titanium in the Development of Yellow Nail Syndrome.

Authors:  Ashley Decker; Deborah Daly; Richard K Scher
Journal:  Skin Appendage Disord       Date:  2015-02-11

2.  Yellow nail syndrome accompanied by minimal-change nephrotic syndrome: A case report.

Authors:  Ya-Nan Zhang; Mei-Hua Wang; Wen-Cheng Yu; Wei Cheng; Jin-Peng Cong; Xue-Peng Huang; Fang-Fang Wang
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

3.  Primary Intestinal Lymphangiectasia Manifested as Unusual Edemas and Effusions: A Case Report.

Authors:  Xuefeng Wang; Hong Jin; Weilu Wu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 4.  Yellow nail syndrome: a review.

Authors:  Stéphane Vignes; Robert Baran
Journal:  Orphanet J Rare Dis       Date:  2017-02-27       Impact factor: 4.123

5.  Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome.

Authors:  Isano Hase; Kazuhiro Kurasawa; Hidenori Takizawa; Bunpei Yamaguchi; Hideo Sakuma; Yoshiki Ishii
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

6.  Effectiveness of clarithromycin in patients with yellow nail syndrome.

Authors:  Sachi Matsubayashi; Manabu Suzuki; Tomoyuki Suzuki; Ayako Shiozawa; Konomi Kobayashi; Satoru Ishii; Motoyasu Iikura; Shinyu Izumi; Koichiro Kudo; Haruhito Sugiyama
Journal:  BMC Pulm Med       Date:  2018-08-15       Impact factor: 3.317

7.  An autopsy case report of yellow nail syndrome coincided with primary biliary cholangitis.

Authors:  Takafumi Kato; Shinobu Akagawa; Kei Kusaka; Masahiro Kawashima; Nobuharu Ohshima; Masashi Kitani; Akira Hebisawa; Hirotoshi Matsui
Journal:  Respir Med Case Rep       Date:  2020-12-31

8.  Yellow Nail Syndrome with Bilateral Pleural Plaques and Diffuse Pleural Thickening: A Mimic of Asbestos Related Disease.

Authors:  Adam Dallmann; Richard L Attanoos
Journal:  Case Rep Pulmonol       Date:  2018-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.